If you save one life, it is as if you have saved the world.
The Talmud is massive there are two versions, the Babylonian one has more than 2,700 pages, and those pages are filled not only with abstract, abstruse legal arguments but also with pithy aphorisms, as well as all sorts of other verbal flourishes.
But its fair to say that the saying about the importance of saving one life, about the entire world that one life encompasses, is among the Talmuds most famous.
Get The Jewish Standard Newsletter by email and never miss our top storiesFree Sign Up
Saving a human life seems like it would be difficult. How do you do that? Fight fires? Perform emergency surgery? Stop a war?
Those would be great things to do, but theres an easier way.
Get your cheek swabbed. Not swabbed in an intrusive, up-your-nose way, as if its a test for covid. No, just a gentle Q-Tip brush of every quartile of your mouth, so four little moths-wing touches. Then, if youre doing it at home, you put the swab in an envelope and mail it back postage is provided and wait.
Every one out of approximately 430 or so would-be donors is a match. After other testing to confirm that match, and to make sure that other factors dont rule that person out, the donor is hooked up to a machine that draws blood, removes the stem cells it needs, and then returns the rest of the blood to the donor. It takes an hour or two.
It doesnt hurt. Its not intrusive. And it can save a life.
The registry will match any recipient with any donor; drives are held both to help everyone but also more specifically to help one person who is in immediate and often desperate need of a match.
The drive thatll be held on Sunday at Congregation Bnai Israel in Emerson, and online until a match is found, is for Judy Fine-Edelstein.
Dr. Fine-Edelstein really does contain worlds.
Judy and Barbara Fine grew up in Bayside, Queens, in a two-family house they shared with their mothers parents, as Judys two-year-younger sister, now Barbara Buxbaum of Chappaqua, said.
Judy was the kind of older sister every younger kid wants; sweet, bright, energetic, and loving, as Barbara said, and also outgoing and emotionally generous. She has a real spark, Ms. Buxbaum added. She can start a conversation with anybody.
Judy Fine left Queens for Boston, where she graduated from BU, worked in healthcare, eventually in a head trauma center, and then decided to go to medical school. I have a strong image from when she worked there, Ms. Buxbaum said. She worked with people who were severely brain injured. She really got close to them. She treated them with respect and love. She was playful with them. I was in awe of her.
I watched her connection with one of the patients, who was in his 20s. Hed been in a motorcycle accident. I dont know how much he was aware of, but she treated him like any other person. She was so animated with him. The connection was remarkable.
Dr. Fine went to medical school at Tufts, and specialized in neurology; her most recent position was as chief of neurology at the Cambridge Health Alliance.
When she was a resident, she met a young man doing his residency in urology. She and Robert Edelstein got married 30 years ago, and they had two children, Ben, who is 27 now, and Emily, who is 25. Dr. Edelstein is a surgeon; he also plays many musical instruments. Beyond that, he is a luthier; he makes stringed instruments. He also makes watches, Ms. Buxbaum said. He has manual dexterity and such patience, and such attention to detail. I am in awe.
Their lives went on. The sisters parents, Eugene and Ruth, continued to flourish in Queens; Judy and Barbara remained close, visiting each other frequently as their families grew. Dr. Fine-Edelstein continued to be passionate about her work. Eugene Fine was diagnosed with macular cancer; it could have been disastrous, but he had the right doctor, and he was saved. Barbara Buxbaum had cancer; she recovered. One of her closest childhood friends, Betsy Blank, died of cancer on Judys birthday, and it hit Barbara hard shed been one of Betsys most devoted supporters but life went on.
Emily Edelstein, Judy Fine-Edelstein, Ben Edelstein, Rachel Starr, and Robert Edelstein, at Rachel and Bens recent wedding.
Meanwhile, Dr. Fine-Edelstein, who was working really hard, was deeply involved with her husband, her children, and her community, and was finding excitement and challenge in her music, started coughing. And coughing. And then coughing some more. She didnt really check it out, her sister said. Maybe in a cursory way, through colleagues, but not in-depth. She was busy.
Covid hit, and like so many other physicians and other healthcare professionals, Dr. Fine-Edelstein pivoted. She was working in neurology, but then she started to help covid patients. Some of it was telemedicine, and some of it was in person. And she kept coughing, and I started thinking This girl has covid.
But it was leukemia. And the diagnosis was on her birthday, and five years to the day after Ms. Buxbaums friend Betsy died.
Dr. Fine-Edelstein underwent treatment. Its brutal, but it seemed to work. She went into remission. During that time, her son, whose plans included a wedding that had been postponed, rescheduled it for as soon as his mother was able to celebrate with him.
The wedding of Ben Edelstein and Rachel Starr, like most covid weddings, was far smaller and less overtly fairy-tale than it would have been; only parents, siblings, and grandparents could be there. (All of the couples grandparents are alive, although one set of them live on the West Coast and could be present only on Zoom, like many other close family members.)
The joy was palpable, Ms. Buxbaum said; it pulsed over Zoom. It had its own claim to fairy-tale status.
And then Dr. Fine-Edelstein relapsed. Its devastating news, her sister said. Shes back in the hospital now, undergoing more extremely harsh treatment to prepare her for the stem cell transplant, should it happen. Judy has held up really well, Ms. Buxbaum said. She is careful about wearing her mask and avoiding germs, and she is remarkable in terms of positivity.
When she got the relapse news, she invited everybody to gather in her house. Me, my husband, our parents, Gail and her husband thats her sons new in-laws, Gail and Michael Starr. We hugged and we cried and we also laughed, and we barbecued.
It was lovely. It was a celebration of life.
Like anyone else who would be going into the hospital, she was fearful, of course. But she is the type of person who also is always thinking I will be bored. So I will need to bring my cello.
So she did. Cellos are not usually welcome in hospitals, Ms. Buxbaum said, but her sisters is.
Gail Starr of River Vale also is a physician; shes a radiologist affiliated with Hackensack Meridian. She and her family are longtime members of Bnai Israel.
Dr. Starr stresses how important it is to find a match for a stem cell transplant. Because of the way genetics work, its generally easier to find a match within a patients ethnic group; in this case, its Ashkenazi Jews. And the search centers on people from 18 to 35 years old, because they tend to be the healthiest, and their stem cells are most plentiful, she said. People of any age up to 60 can donate, but more than 80 percent of donors end up in that age group. The clinical outcome is likely to be better if the donor is younger.
There are many registries, but the one that Dr. Fine-Edelstein is using, Gift of Life, focuses on Ashkenazim. If you end up being selected as a donor, any expenses related to travel or any physical that you might have will be covered, Dr. Starr said. Gift of Life is an amazing organization.
Families cant always provide matches, she said; Ms. Buxbaum would love to donate her own stem cells to her sister, but shes an imperfect match because of her age, her medical history, and the fact that siblings generally can provide no more than a 50 percent match. More would be better; counterintuitively, better often can come from strangers.
Then she moved from the general to the specific. Judy is a very special person, Dr. Starr said. She has a huge heart, she is a wonderful physician, and above and beyond that she helps anyone and everyone in need. Shes currently helping several friends and neighbors navigate their own cancers. She pivoted during the pandemic to help others. Shes a loving daughter, sister, mother, aunt, cousin and friend. She is an all-around terrific person.
This is a difficult time, but we remain hopeful, Dr. Starr said.
Lenny Mandel of West Orange is the cantor at Bnai Israel. (Im also the Jewish chaplain for the Livingston fire department, he said.) Hes known the Starrs for a very long time, and he performed Ben and Rachels wedding. Hes funny and warm and open-hearted; he loves the Starrs, thinks that Ben is good enough for Rachel, and becomes deeply serious when he talks about Judy Fine-Edelstein and her need for a stem-cell match.
Getting tested is a no-brainer, Cantor Mandell said. said. Its not like youre giving somebody a kidney. Theyre not cutting you open.
This is really a chance to save a life. And you dont really even have to do anything.
He who saves one life saves the whole world. This is really what this is all about. So why not do it? And its not just about Jews. Every person should be aware that they have the chance to make a difference in someones life.
You can be as spiritual as you want. You can be as observant as you want. But this is not about making the way you say the Shema perfect. Its about tikkun olam. Its about making the world more perfect.
Its like the old song, Cantor Mandel said. We are the world. We can make a better world, just you and me.
Every person who does this swab makes this world a better place.
Who: The Gift of Life Bone Marrow Registry
Again who: Asks that all healthy people from 18 to 35
What: Either go to Congregation Bnai Israel,53 Palisades Ave. in Emerson
When: Sunday, July 25, from 10 a. m. to 1 p.m.
What: Order a kit (its free both to receive and to return) fromgiftoflife.org/Judy
Why: For a swab test to see if youre able to donate stem cells to Dr. Judy Fine-Edelstein or anyone else you might match.
Note: You can register if youre over 35, but theres a $60 fee.
For more information: Call Bnai Israel at (201) 265-2272.
Originally posted here:
- Issue: Cell Stem Cell - August 2nd, 2021
- Stem Cell Therapy & Alternative Medicine in Mexico ... - August 2nd, 2021
- Fetal Stem Cell - an overview | ScienceDirect Topics - August 2nd, 2021
- Stem cell therapy - SlideShare - August 2nd, 2021
- Essent Biologics Launches Human Mesenchymal Stem Cells For ... - August 2nd, 2021
- From Cells to Organs: The Present and Future of Regenerative Medicine - DocWire News - August 2nd, 2021
- USC Stem Cell scientists explore the latent regenerative potential of the inner ear - USC News - August 2nd, 2021
- Refining epilepsy treatment with brain organoids and AI - Monash University - August 2nd, 2021
- Astellas and Minovia link up on mitochondrial cell therapy programs - The Pharma Letter - August 2nd, 2021
- Stem Cell Scientists Explore the Latent Regenerative Potential of the Inner Ear - SciTechDaily - July 31st, 2021
- Colin Jackson health: Im in constant pain Athlete to undergo stem cell therapy to help - Express - July 31st, 2021
- The Talking Man: New Advances In Regenerative Medicine - Forbes - July 31st, 2021
- Medipost's clinical trial approved to evaluate efficacy of knee osteoarthritis treatment - Aju Business Daily - July 31st, 2021
- A Phase II Study of Polatuzumab Vedotin with Rituximab, Ifosfamide, Carboplatin, and Etoposide Before Stem Cell Transplantation in People with... - July 31st, 2021
- Background should not be a barrier to access stem cell transplant treatment and care - PoliticsHome - July 31st, 2021
- Treatment Approaches for Patients With R/R DLBCL - Targeted Oncology - July 31st, 2021
- Global $57.4 Billion Cell And Gene Therapy Manufacturing Market to 2028 - Rising Pressure on Drug Developers/Manufacturers to Meet the Growing Market... - July 31st, 2021
- Acute Myeloid Leukemia Fungal Infections: Types and Treatment - Healthline - July 31st, 2021
- Overview of DLBCL - Targeted Oncology - July 31st, 2021
- Roundtable Discussion: Participants Evaluate the Use of Transplant and MRD in Newly Diagnosed Multiple Myeloma - Targeted Oncology - July 31st, 2021
- Hematopoietic Stem Cell Transplantation (HSCT) Market: Allogeneic transplant is projected to continue to hold a dominant market share - BioSpace - July 27th, 2021
- Researchers develop a cell culture test to detect substances that harm the placenta and embryo - News-Medical.net - July 27th, 2021
- FDA Approves KEYTRUDA (pembrolizumab) for Treatment of Patients With High-Risk Early-Stage Triple-Negative Breast Cancer in Combination With... - July 27th, 2021
- Cryopreservation of Unrelated Donor SCTs Safe, Effective in Patients Who Underwent HSCT - Hematology Advisor - July 27th, 2021
- Combination drug therapy can significantly benefit patients with newly diagnosed blood cancer - The Institute of Cancer Research, London - The... - July 25th, 2021
- Study proposes repurposed drug to treat COVID-19 - The Hindu - July 25th, 2021
- Injecting mice with pulmonary endothelial cells can reverse symptoms of emphysema - News-Medical.Net - July 25th, 2021
- FDA gives speedy review to Bayer's Parkinson's stem cell therapy - - pharmaphorum - July 23rd, 2021
- Stemming the tide of stem-cell treatment scams - Houston Chronicle - July 23rd, 2021
- Regenerative Medicine provides new hope and healing - Summit Daily News - July 23rd, 2021
- Emphysema Reversed in Mice Given Injection of Healthy Pulmonary Endothelial Cells - Genetic Engineering & Biotechnology News - July 23rd, 2021
- Nelson: Gimpy girls have different means of recovery - Watertown Public Opinion - July 23rd, 2021
- Gene Therapy Protects Optic Nerve Cells and Vision in Mice with Retinal Injury and Glaucoma - Genetic Engineering & Biotechnology News - July 23rd, 2021
- Has COVID-19 Opened up the Route to Market for Cell and Gene Therapy? - Pharmaceutical Executive - July 23rd, 2021
- Transplant-Associated Thrombotic Microangiopathy: New Insights, Emerging Treatments - OncLive - July 23rd, 2021
- Bluebird, with little fanfare, is first to bring a second gene therapy to market - BioPharma Dive - July 23rd, 2021
- Belumosudil Granted Full Approval for Treatment of Chronic GVHD by FDA - Cancer Network - July 21st, 2021
- Creative Medical Technology Holdings Announces MyeloCelz The Company's Second Regenerative Immunotherapy Product - PRNewswire - July 21st, 2021
- Stem Cell Therapy Gets Fast Track Status for Parkinson Disease - Monthly Prescribing Reference - July 21st, 2021
- Stem cell model reveals how COVID-19 can infect the brain - Study Finds - July 21st, 2021
- Donating a chance at life: Kokomo teacher donates stem cells to 75-year-old woman through Be the Match - Kokomo Perspective - July 21st, 2021
- Young Patients With Multiple Myeloma May Benefit From Tandem Autologous Hematopoietic Stem Cell Transplantation - Hematology Advisor - July 21st, 2021
- Emerging Quadruplets, Novel Targets, and Immunotherapy Advances Personalized Medicine in Multiple Myeloma - OncLive - July 21st, 2021
- BlueRock Therapeutics Receives FDA Fast Track Designation for DA01 in the Treatment of Advanced Parkinson's Disease - Yahoo Finance - July 21st, 2021
- YOUR HEALTH: Finding cures by tracking cells - WQAD.com - July 21st, 2021
- Study shows promise of combining radiation therapy with dendritic-cell vaccines for breast cancer - News-Medical.Net - July 21st, 2021
- Profilin 1 Protein and Its Implications for Cancers - Cancer Network - July 17th, 2021
- Developmental Interest in Allogeneic PlacentaDerived Cell Therapies Expands - OncLive - July 17th, 2021
- For Patients with HIV and Cancer, a Multidisciplinary Treatment Approach is Critical - Targeted Oncology - July 17th, 2021
- Times really up! FDA authority to crack down on regenerative medicines upheld as grace period ends - JD Supra - July 15th, 2021
- The Memphis Institute of Regenerative Medicine Rebrands To Reflect Statewide Reach - UTHSC News - July 15th, 2021
- Dr. Sperling on Future Research With CAR T-Cell Therapy in Multiple Myeloma - OncLive - July 15th, 2021
- TiTAN-1 Trial of GEN-011 Initiates Treatment in Patients With Solid Tumors - Targeted Oncology - July 15th, 2021
- Exosome spray may be better able to heal damaged hearts - New Atlas - July 15th, 2021
- Prime Medicine uncloaks with $315M to push 'search and replace' gene editing treatments - FierceBiotech - July 13th, 2021
- Dr. Sallman on Unmet Treatment Needs in Higher-Risk MDS - OncLive - July 13th, 2021
- U.S. Stem Cell, Inc The New Generation Company In The ... - July 11th, 2021
- Stem Cell Therapy - Stemedix | Regenerative Medicine Also ... - July 11th, 2021
- FIRM, CAS further cooperate to advance reproductive medicine research_china.org.cn - China.org.cn - July 11th, 2021
- England's drug price watchdog rejects Orchard's groundbreaking gene therapy after first round of talks - FiercePharma - July 11th, 2021
- ARO-HIF2 Shows Signals of Activity, Safety in Clear Cell Renal Cell Carcinoma - Targeted Oncology - July 9th, 2021
- Gene therapy for sickle cell disease: progress and competition - BioPharma Dive - July 9th, 2021
- Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere... - July 9th, 2021
- Dr. Sperling on Future Research Directions With Ide-Cel in Multiple Myeloma - OncLive - July 9th, 2021
- More than $25m awarded to Monash researchers for vital medical research - Monash University - July 9th, 2021
- Magnetically-guided delivery of therapeutic stem cells into the brain - Advanced Science News - July 7th, 2021
- Beyond CAR-T: New Frontiers in Living Cell Therapies - UCSF News Services - July 7th, 2021
- Stem cell therapy could make significant impact as opioid alternative - The Pharma Letter - July 7th, 2021
- Institute for Stem Cell Biology and Regenerative Medicine ... - July 5th, 2021
- Home - World Stem Cell Summit - July 5th, 2021
- Stem Cell Therapy & Regenerative Medicine Clearwater, FL ... - July 5th, 2021
- Ethical Issues in Stem Cell Research - July 5th, 2021
- Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030 - ResearchAndMarkets.com - Business Wire - July 3rd, 2021
- Regenerative Therapy Makes Headway in HF ... in the Right Patients - MedPage Today - July 3rd, 2021
- A New Era For FDA Regulation Of Cell And Tissue Products - Law360 - July 3rd, 2021
- Multiple myeloma treatment: Newest options, drugs, and more - Medical News Today - July 3rd, 2021
- Anti-CD22 CAR-T cell therapy as a salvage treatment - OTT | OTT - Dove Medical Press - July 3rd, 2021
- Studies Offer Promising Data on CAR T-cell Therapy in B-ALL, Multiple Myeloma - AJMC.com Managed Markets Network - July 3rd, 2021
- The cell therapy manufacturing market is projected to reach USD 14.5 billion by 2030, growing at - GlobeNewswire - July 3rd, 2021
- Cellular Model of a Developing Mouse Is Built With Spatial Resolution - Technology Networks - July 3rd, 2021